Biotalys Welcomes Luc Van Fraeyenhoven as New CFO
Biotalys, a pioneering Agricultural Technology (AgTech) company focused on developing innovative protein-based biocontrol solutions, has officially appointed Luc Van Fraeyenhoven as their new Chief Financial Officer (CFO). This announcement marks a significant moment for the company as it continues to enhance its leadership team to drive future growth and sustainability initiatives.
Experience and Background
Luc Van Fraeyenhoven comes to Biotalys with a wealth of experience, having spent over 30 years in various financial roles across biotechnology and medtech sectors. His impressive track record includes key executive positions such as CFO for notable companies like Arseus Medical, ActoBio Therapeutics, and the Akkermansia Company. Most recently, he held a prominent position at the Kebony Group, reinforcing his expertise in financial management and strategic planning. Additionally, Van Fraeyenhoven has also contributed significantly to Volvo Cars in various finance leadership capacities.
Vision for the Future
Simon Moroney, the Chairman of the Board at Biotalys, remarked on the importance of Luc's appointment during this pivotal time. He expressed optimism about Luc’s ability to provide essential financial leadership as Biotalys advances its innovative product pipeline. With Luc's guidance, the company aims to align its financial strategies with operational needs, ensuring both immediate and long-term success.
Strategic Goals and Stewardship
CEO Kevin Helash highlighted that Van Fraeyenhoven will play a critical role in partnering with the management and board members to enhance the commercialization of their groundbreaking products while being mindful of resource allocation. His extensive background and knowledge in the biotechnology industry positions him as an essential asset to Biotalys as they chart their course towards a sustainable and efficient future.
Personal Insights from the New CFO
In his statements, Luc expressed his enthusiasm about joining the Biotalys team and his commitment to acting as a valuable resource across the organization. He acknowledged Biotalys' unique position in the agricultural and biotech landscape and articulated his eagerness to contribute to the development of sustainable technologies that benefit the agricultural sector.
About Biotalys
Founded as a spin-off from the VIB, Biotalys is committed to delivering leading-edge solutions that offer environmentally friendly alternatives to traditional chemical pesticides. Their innovative AGROBODY™ technology platform is driving the development of a diverse array of product candidates designed to ensure crop safety and effectiveness across the agricultural value chain.
Since its listing on Euronext Brussels in July 2021, Biotalys continues to grow and evolve within the biotech cluster in Ghent, Belgium. Their commitment to sustainability is reflected in their ongoing efforts to enhance food safety and improve agricultural practices globally. For additional information about their projects and initiatives, visit the company’s website.
Contact Information
For further inquiries, please reach out to:
Toon Musschoot, Head of IR & Communication
T: +32 (0)9 274 54 00
E: IR@biotalys.com
Frequently Asked Questions
Who is Luc Van Fraeyenhoven?
Luc Van Fraeyenhoven is the newly appointed Chief Financial Officer of Biotalys, bringing over 30 years of financial experience to the role.
What is Biotalys known for?
Biotalys specializes in developing protein-based biocontrol solutions for sustainable agriculture, creating alternatives to chemical pesticides.
Why is Luc's appointment significant?
His extensive experience in the biotechnology sector is expected to greatly enhance Biotalys' financial strategies and operational management.
What is AGROBODY™ technology?
AGROBODY™ technology is Biotalys' innovative platform that supports the development of effective agricultural products aimed at ensuring crop safety.
How can I contact Biotalys for more information?
You can contact Toon Musschoot, Head of IR & Communication, at +32 (0)9 274 54 00 or via email at IR@biotalys.com.
